Lu Kang Biochemical: Planning for Change in Control Rights, Stock to Resume Trading on April 28th.

Green Kang Biochemical announced that the company's controlling shareholder, Shanghai Kangyi Investment Co., Ltd., and others have signed relevant documents such as the "Share Transfer Agreement" with Fujian Zongteng Network Co., Ltd. However, this share transfer still requires the approval of the Green Kang Biochemical shareholders' meeting to waive the obligation of the company's actual controlling shareholder to reduce their holdings, and it also requires confirmation of the compliance of the share transfer by the Shenzhen Stock Exchange, as well as the transfer of relevant transfer procedures at the Shenzhen branch of China Securities Depository and Clearing Corporation Limited. Therefore, there is still uncertainty as to whether this transaction will ultimately be completed and its results implemented. The company's stock will resume trading from April 28, 2025.